Notably, 8aa potently inhibited the EGFR and EGFR-mediated signaling pathways such as AKT and ERK1/2 in a dose-dependent manner, and it also showed selective reductions in cell viability against human NSCLC cell lines PC9 and A549. Here, MAPK3 is linked to non-small cell lung carcinoma.